Piper Sandler Maintains Overweight on OrthoPediatrics, Lowers Price Target to $30

Benzinga · 05/08 16:33
Piper Sandler analyst Matt O'Brien maintains OrthoPediatrics (NASDAQ:KIDS) with a Overweight and lowers the price target from $40 to $30.